Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion

Neurochemistry International

Volumn 62, Issue 2, 2013, Pages 157-164

  Wu, Xiaomei ^a   Zhou, Cheng ^a   Du, Fang ^a   Lu, Yapeng ^a   Peng, Bin ^a   Chen, Lei ^a   Zhu, Li ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Astrocyte; Astrocyte conditioned medium; Erythropoietin; Ginkgolide B; Ischemia; Ischemic preconditioning; Neuron

Indexed keywords

ERYTHROPOIETIN; GINKGOLIDE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL SURVIVAL; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; ISCHEMIC PRECONDITIONING; MAMMAL; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GINKGOLIDES; ISCHEMIC PRECONDITIONING; LACTONES; MICE; MICE, INBRED ICR; NEURONS; REPERFUSION INJURY; UP-REGULATION;

MAMMALIA;

EID: 84871893820     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.11.007     Document Type: Article

References (41)

1. J.M. Adams Ways of dying: multiple pathways to apoptosis Genes Dev. 17 2003 2481 2495
2. B. Andreas Survival signaling goes BAD Dev. Cell 3 2002 607 608
3. L. Barrier, S. Ingrand, A. Piriou, A. Touzalin, and B. Fauconneau Lactic acidosis stimulates ganglioside and ceramide generation without sphingomyelin hydrolysis in rat cortical astrocytes Neurosci. Lett. 385 2005 224 229
4. C. Bate, S. Kempster, and A. Williams Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death Neuropharmacology 51 2006 173 181
5. K.F. Bell, B. Al-Mubarak, J.H. Fowler, P.S. Baxter, K. Gupta, T. Tsujita, S. Chowdhry, R. Patani, S. Chandran, K. Horsburgh, J.D. Hayes, and G.E. Hardingham Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning Proc. Nat. Acad. Sci. 108 2011 E1 E2
6. M. Bernaudin, A.-S. Nedelec, D. Divoux, E.T. MacKenzie, E. Petit, and P. Schumann-Bard Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain J. Cereb. Blood Flow Metab. 22 2002 393 403
7. V.A. Bhattaram, U. Graefe, C. Kohlert, M. Veit, and H. Derendorf Pharmacokinetics and bioavailability of herbal medicinal products Phytomedicine 9(3) 2002 1 33
8. Y. Chen, and R.A. Swanson Astrocytes and brain injury J. Cereb. Blood Flow Metab. 23 2003 137 149
9. B. Cheng, W. Wang, L. Lin, F. Li, and X. Wang The change of the spinal cord ischemia-reperfusion injury in mitochondrial passway and the effect of the Ginkgo biloba extract's preconditioning intervention Cell Mol. Neurobiol. 31 2010 415 420
10. X. Chu, X. Ci, J. He, M. Wei, X. Yang, Q. Cao, H. Li, S. Guan, Y. Deng, D. Pang, and X. Deng A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK/MAPK signaling pathway Molecules 16 2011 7634 7648
11. H.S. Chung, A. Harris, J.K. Kristinsson, T.A. Ciulla, C. Kagemann, and R. Ritch Ginkgo biloba extract increases ocular blood flow velocity J. Ocul. Pharmacol. Ther. 15 1999 233 240
12. K.F. Chung, G. Dent, M. McCusker, P. Guinot, C.P. Page, and P.J. Barnes Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man Lancet 1 1987 248 251
13. K.M. Dhandapani, M. Hadman, L. De Sevilla, M.F. Wade, V.B. Mahesh, and D.W. Brann Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway J. Biol. Chem. 278 2003 43329 43339
14. M. Digicaylioglu, and S.A. Lipton Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades Nature 412 2001 641 647
15. U. Dirnagl, R.P. Simon, and J.M. Hallenbeck Ischemic tolerance and endogenous neuroprotection Trends Neurosci. 26 2003 248 254
16. U. Dirnagl, K. Becker, and A. Meisel Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use Lancet Neurol. 8 2009 398 412
17. D. Fang, Z. Li, Q. Zhong-ming, W.X. Mei, Y.W. Ho, X.W. Yuan, and K. Ya Expression of bystin in reactive astrocytes induced by ischemia/reperfusion and chemical hypoxia in vitro Biochim. et Biophys. Acta (BBA): Mol. Basis of Diseases 1782 2008 658 663
18. W. Fang, Y. Deng, Y. Li, E. Shang, F. Fang, P. Lv, L. Bai, Y. Qi, F. Yan, and L. Mao Blood brain barrier permeability and therapeutic time window of ginkgolide B in ischemia-reperfusion injury Eur. J. Pharm. Sci. 39 2010 8 14
19. J.B. Fourtillan, A.M. Brisson, J. Girault, I. Ingrand, J.P. Decourt, K. Drieu, P. Jouenne, and A. Biber Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761) Therapie 50 1995 137 144
20. J.J. Freiberger, H.B. Suliman, H. Sheng, J. McAdoo, C.A. Piantadosi, and D.S. Warner A comparison of hyperbaric oxygen versus hypoxic cerebral preconditioning in neonatal rats Brain Res. 1075 2006 213 222
21. V.L. Gabai, K. Mabuchi, D.D. Mosser, and M.Y. Sherman Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis Mol. Cell Biol. 22 2002 3415 3424
22. Y. Hao, Y. Sun, C. Xu, X. Jiang, H. Sun, Q. Wu, C. Yan, and S. Gu Improvement of contractile function in isolated cardiomyocytes from ischemia-reperfusion rats by ginkgolide B pretreatment J. Cardiovasc. Pharmacol. 54 2009 3 9
23. H. Kitano, J.R. Kirsch, P.D. Hurn, and S.J. Murphy Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain J. Cereb. Blood Flow Metab. 27 2006 1108 1128
24. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, I. Khan, W.J. Netzer, H. Xu, and P. Butko Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 Proc. Nat. Acad. Sci. 99 2002 12197 12202
25. K.M. Maclennan, C.L. Darlington, and P.F. Smith The CNS effects of Ginkgo biloba extracts and ginkgolide B Prog. Neurobiol. 67 2002 235 257
26. C. Malagelada, E.J. Ryu, S.C. Biswas, V. Jackson-Lewis, and L.A. Greene RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation J. Neurosci. 26 2006 9996 10005
27. H. Manev, S. Caredda, and D.R. Grayson Nonselective inhibition by antisense oligonucleotides of cytosine arabinoside action NeuroReport 2 1991 589 592
28. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
29. S.E. Nada, and Z.A. Shah Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2 Neurobiology Disorder 46 2012 180 189
30. M. Navarrete, and A. Araque Endocannabinoids mediate neuron-astrocyte communication Neuron 57 2008 883 893
31. K.S. Panickar, and M.D. Norenberg Astrocytes in cerebral ischemic injury: morphological and general considerations Glia 50 2005 287 298
32. J. Rossert, and K.-U. Eckardt Erythropoietin receptors: their role beyond erythropoiesis Nephrol. Dial. Transplant. 20 2005 1025 1028
33. K. Ruscher, D. Freyer, M. Karsch, N. Isaev, D. Megow, B. Sawitzki, J. Priller, U. Dirnagl, and A. Meisel Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model J. Neurosci. 22 2002 10291 10301
34. M. Silva, A. Benito, C. Sanz, F. Prosper, D. Ekhterae, G. Nuñez, and J.L. Fernandez-Luna Erythropoietin can induce the expression of Bcl-xLthrough Stat5 in erythropoietin-dependent progenitor cell lines J. Biol. Chem. 274 1999 22165 22169
35. O. Sporns, G.M. Edelman, and K.L. Crossin The neural cell adhesion molecule (N-CAM) inhibits proliferation in primary cultures of rat astrocytes Proc. Nat. Ac. Sci. USA 92 1995 542 546
36. T.W. Stone Pre-conditioning protection in the brain Br. J. Pharmacol. 140 2003 229 230
37. G. Trendelenburg, and U. Dirnagl Neuroprotective role of astrocytes in cerebral ischemia: Focus on ischemic preconditioning Glia 50 2005 307 320
38. L. Wang, R.J. Traystman, and S.J. Murphy Inhalational anesthetics as preconditioning agents in ischemic brain Curr. Opin. Pharmacol. 8 2008 104 110
39. X.-M. Wu, Z.-M. Qian, L. Zhu, F. Du, W.-H. Yung, Q. Gong, and Y. Ke Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801 Br. J. Pharmacol. 164 2011 332 343
40. X. Wu, Z. Qian, Y. Ke, F. Du, and L. Zhu Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis J. Cell Mol. Med. 13 2009 4474 4483
41. T. Yamada, K. Kawahara, T. Kosugi, and M. Tanaka Nitric oxide produced during sublethal ischemia is crucial for the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures Neurochem. Res. 31 2006 49 56